We tried to clarify the pharmaceutical properties of heparinoid oil-based cream (HPOC) formulations from various aspects, such as rheological properties. Furthermore, the stability of the mixture of droplet dispersion type betamethasone butyrate propionate ointment (BBPO) formulations and all HPOC formulations at various mixing ratios was evaluated.